세계의 2웨이 폴리 카테터 시장 : 시장 규모, 점유율, 동향 분석 - 재료별, 적응증별, 사용법별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

2-way Foley Catheter Market Size & Trends:

The global 2-way foley catheter market size was estimated at USD 280.26 million in 2024 and is projected to grow at a CAGR of 5.44% from 2025 to 2030. This growth is driven by several key factors, including the rising prevalence of urological disorders such as urinary incontinence and bladder cancer, and an increasing preference for minimally invasive surgeries. Moreover, advancements in healthcare infrastructure, particularly in developing regions, are anticipated to further contribute to the market's expansion.

The increasing prevalence of kidney stone disease, cystitis, benign prostatic hyperplasia, and other urinary tract disorders is expected to drive the 2-way foley catheters industry during the forecast period. According to the data published by the American Kidney Fund , in May 2024, kidney stones affected over 1 in 10 men and 1 in 14 women in the U.S., causing significant discomfort and urinary obstruction. As the incidence of these conditions rises, along with an aging population, the demand for effective management solutions like 2 way foley catheters is also increasing.

The demand for 2-way Foley catheters is also driven by the increasing number of surgeries, especially urological and gynecological procedures, and growing rates of conditions like prostate enlargement, which may necessitate catheter use. According to the data published by the National Institute of Diabetes and Digestive in March 2025, benign prostatic hyperplasia (BPH) affects 5% to 6% of men aged 40 to 64 and 29% to 33% of those aged 65 and older. Thus, such a large proportion of the population suffering from urinary disorders increases the need for reliable and effective urinary drainage solutions like 2-way Foley catheters, further driving their demand in healthcare settings.

Technological advancements to streamline procedures and make them safer and more cost-effective are key factors driving the market's growth. For instance, the LECS II, a device, was launched to stabilize a 2-way foley catheter. It features a head that rotates 180 degrees, adjusting to patient movements and reducing urethral discomfort during daily activities. With such ongoing product developments and innovations, the 2-way foley catheter industry is expected to experience significant growth in the forecasted period.

Global 2-way Foley Catheter Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 2-way foley catheter market report based on material, indication, usage, end use, and region:

• Material Outlook (Revenue, USD Million, 2018 - 2030)
• Silicone Foley Catheters
• Latex Foley Catheters
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Urinary Incontinence
• Enlarged Prostate Gland/BPH
• Spinal Cord Injury
• Others
• Usage Outlook (Revenue, USD Million, 2018 - 2030)
• Short-Term Use
• Long-Term Use
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Long Term Care Facilities
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Indication
  • 1.2.3. Usage
  • 1.2.4. End use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Global 2-way Foley Catheter Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of urinary disorders
    • 3.2.1.2. Growing research and development activities
    • 3.2.1.3. Rising aging population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Product recalls
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing clinical trials
    • 3.2.3.2. Increasing investment in hospitals and surgery centers
    • 3.2.3.3. Advancements in catheters
• 3.3. Global 2-way Foley Catheter Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Legal Landscape
    • 3.3.2.5. Environmental Landscape
    • 3.3.2.6. Social Landscape

Chapter 4. Global 2-way Foley Catheter Market: Material Estimates & Trend Analysis

• 4.1. Global 2-way Foley Catheter Market: Material Dashboard
• 4.2. Global 2-way Foley Catheter Market: Material Movement Analysis
• 4.3. Global 2-way Foley Catheter Market by Material, Revenue
• 4.4. Silicone 2-way Foley Catheter
  • 4.4.1. Silicone 2-way Foley catheter market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Latex 2-way Foley Catheter
  • 4.5.1. Latex 2-way Foley catheter market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global 2-way Foley Catheter Market: Indication Estimates & Trend Analysis

• 5.1. Global 2-way Foley Catheter Market: Indication Dashboard
• 5.2. Global 2-way Foley Catheter Market: Indication Movement Analysis
• 5.3. Global 2-way Foley Catheter Market by Indication, Revenue
• 5.4. Urinary Incontinence
  • 5.4.1. Urinary incontinence market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Enlarged Prostate Gland/BPH
  • 5.5.1. Enlarged prostate gland/BPH market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Spinal Cord Injury
  • 5.6.1. Spinal cord injury market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global 2-way Foley Catheter Market: Usage Estimates & Trend Analysis

• 6.1. Global 2-way Foley Catheter Market: Usage Dashboard
• 6.2. Global 2-way Foley Catheter Market: Usage Movement Analysis
• 6.3. Global 2-way Foley Catheter Market by Usage
• 6.4. Short-Term Use
  • 6.4.1. Short-term use market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Long-Term Use
  • 6.5.1. Long-term use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global 2-way Foley Catheter Market: End Use Estimates & Trend Analysis

• 7.1. Global 2-way Foley Catheter Market: End Use Dashboard
• 7.2. Global 2-way Foley Catheter Market: End Use Movement Analysis
• 7.3. Global 2-way Foley Catheter Market by End Use, Revenue
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Long Term Care Facilities
  • 7.5.1. Long term care facilities market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Global 2-way Foley Catheter Market: Regional Estimates & Trend Analysis by Material, Indication, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Sterimed Group.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Material benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. ANGIPLAST PRIVATE LIMITED
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Material benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. HEMC (Hospital Equipment Manufacturing Company)
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Material benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Cardinal Health
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Material benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Advin Health Care
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Material benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. AdvaCare Pharma
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Material benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Teleflex Incorporated
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Material benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Bactiguard AB
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Material benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Medtronic
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Material benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. B. Braun SE
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Material benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Ribbel International Limited
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Material benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. Coloplast Corp
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Material benchmarking
    • 9.3.15.4. Strategic initiatives